HOME      •      SEARCH      •      EMAIL    •     ABOUT

Family Acanthaceae
Barleria cristata Linn.
Jia du juan

Scientific names Common names
Barleria alba Lodd. Kolintang-violeta (Tag.)  
Barleria chegosa Wall. Bluebell barleria (Engl.)  
Barleria ciliata Roxb.  December flower (Engl.)
Barleria cristata L.  Ganges primrose (Engl.)
Barleria cristata var. albida Haines Crested Philippine violet (Engl.)
Barleria cristata var. dichotoma (Roxb.) Prain Philippine violet (Engl.)
Barleria cristata var. lactea Desf. ex Nees  
Barleria cristata var. mairei (H.Lév.) H.P.Tsui  
Barleria dichotoma Roxb.   
Barleria indica L. ex T.Anderson   
Barleria laciniata Wall.   
Barleria lactea Desf. ex Steud.   
Barleria mairei H.Lév.   
Barleria nepalensis Nees    
Barleria nepalensis var. microphylla Nees    
Barleria nuda Nees   
Barleria prinoides Nees   
Barleria venulosa Nees  
Lepidagathis laciniata Wall. ex Nees  
Ruellia ciliata Wall. ex Nees  
Violeta is a shared common name for two species of local medicinal plants: (1) Kolintang-violeta (Barleria cristata Linn.) and (2) Violeta   (Viola odorata Linn.), sweet violet.    
Barleria cristata L. is an accepted species. KEW: Plants of the World Online

Other vernacular names
ASSAMESE: Jhinili.
CHINESE: Jia du juan.
FIJIAN: Tombithi.
FRENCH: Gueule de loup.
HAITIAN: Harre-vole; Jolie-jolie.
JAPANESE" Barureria.
ORIYA: Koilekha, Banpatoli.
SPANISH: Violeta.
TAMIL: Semmulli, December poo.
TELUGU: Tellanilambari, Decembaralu.
THAI: Kaanchang, Luem thao yai, Thong ra-aa.
TIBET: Sa ha ra ca, Sa ha ratsap, Sa-ha-tsa.
VIETNAMESE: Hoach[oo]ng.

Gen info
- Barleria is a genus of plants in the family Acanthaceae. It includes 303 species native to the tropics and subtropics.

• Kolintang-violeta is an erect, unarmed, branched ornamental shrub, 1 to 3 meters high. Branches are sparingly hairy. Leaves are oblong to elliptic, 4 to 10 centimeters long, pointed at the tip and somewhat hairy beneath. Flowers are borne singly or in pairs, and terminal or in the upper axils of the leaves. Bracteoles are linear. Two outer sepals are green, ovate-lanceolate, nearly 2 centimeters long, persistent, and laciniately toothed. Corolla is 6 to 7 centimeters long, slender-tubed, winged above; limb is 4 to 5 centimeters in diameter, violet or nearly white, or streaked with violet and white.

- Native to the Philippines.
- Widely cultivated ornamental hedge plant.
- Also native to
Andaman Is., Assam, Bangladesh, Cambodia, China South-Central, China Southeast, East Himalaya, Hainan, India, Jawa, Laos, Malaya, Myanmar, Nepal, New Guinea, Pakistan, Panamá, Sri Lanka, Taiwan, Thailand, Vietnam, West Himalaya. (12)
- In Australia, listed as an environmental weed.

- Phytochemical screening of crude extract of leaves yielded amino acids, carbohydrates, flavonoids, proteins, phenolic groups, saponins steroids, tannins, and terpenoids. (9)
- Three phenylethanoid glycosides viz; (desrhamnosylacteoside) (1), (acteoside) (2) and (poliumoside) (3) were isolated and identified from the callus cultures of Barleria cristata. (6)
- Study of bark extracts yielded yielded a new flavonoid compound, 6-O-α-L-rhamnopyranoside-3,7,3'-O-trimethylated-8- hydroxyquercetin, together with known flavonoids flavonoids 6- O-α-L-rhamnopyranoside 3-methoxy quercetin, quercetagetin, tamarixetin, gossypetin and quercetin. (See study below) (8)
- Leaf and bark extracts yielded terpenoids, anthraquinones, alkaloids, flavonoids, and saponins. (see study below) (14)
- Study of organic extracts of whole plants of B. cristata isolated 4-hydroxy-trans-cinnamate derivatives (1-3) and a triterpene, namely oleanolic acid (4).
- Study of aerial parts yielded a new iridoid glycoside, barlupulin C methyl ester (1) together with two known phehylethanoid glycosides, poliumoside and decaffeoylacteoside, (2 and 3) and three known phenolic glycosides, protocatechuic acid 4-O-β-glucoside, vanillic acid 4-O-β-glucoside, and leonuriside A (4-6). (see study below) (18)
- Ethanolic extract of leaves have yielded secondary metabolites such as alkaloids, steroids, triterpenes, , phenols, flavonoids, saponins, tannins, proteins, and amino acids. Major phytoconstituents are phenolic compounds, flavonoids, phenylethanoid and iridoidal glycosides.
- Flowers have yielded ß-sitosterol, quercetin, quercetin 3-ß-D-glucoside, apigene, naringenin, and apigenin-7-glucuronide. (19)
- Trace elements in the leaves included lead, zinc, iron, chromium, copper, nickel and cadmium. (19)
- Ethyl acetate fraction yielded five known compounds: verbascoside (1), isoverbascoside (2), dimethoxyverbascoside (3), phydroxy-benzoic acid (4), and apigenin-7-O-glucoside (5). (see study below)
- Study of leaves yielded two phenolic compounds (p-coumaric acid and
α-tocopherol), two flavonoidal compounds (luteoline and 7-methoxy-luteoline), and two iridoidal glycosides (barlerin and schanshiside methyl ester). (25)

- Considered antidotal.
- Studies have suggested antibacterial,  antifungal, anti-inflammatory, antioxidant, hepatoprotective, antidiabetic, mosquitocidal, cardioprotective properties.

Parts used
Roots, leaves, seeds.

- Seeds used as antidote for snake bites.
- Roots and leaves used to reduce swellings.
- Infusion of roots and leaves used for coughs.

- Used for treatment of cough.
- Elsewhere, used for toothaches, anemia and inflammatory disorders.
- In India, used for the treatment of toothache, anemia, snake bites, diabetes, lung disorders, and inflammatory conditions. (19) Infusion of roots and leaves applied to boils and sores to reduce swelling. Decoction or paste of whole plant used for tuberculosis. Seeds used as antidote for snake bites. Bitter juice of leaves and roots used for disphoretic and expectorant properties. (26)
- Used for wounds and burns, gingivitis, nocturnal ejaculation, tuberculosis. (19)
- Leaves chewed for relief of toothaches; plant juices for fever and phlegm; paste applied on feet to prevent cracking; root decoction used for anemia and cough; root infusion applied to boils and sores to diminish swelling; dried bark used for whooping cough. (19)

Anti-Inflammatory / Leaves:
Methanol extract of leaves of Barleria cristata was evaluated for anti-inflammatory activity. The effect was compared to the activity of indomethacin and cyproheptadine as reference standard. Results revealed BC possesses significant anti-inflammatory activity. (1)
Study of aqueous extract of BC leaves exhibited anti-inflammatory activity with significant dose-dependent inhibition of carrageenan-induced paw edema, prostaglandin activity, vascular permeability. (2)
Phytochemicals / Antioxidant Activity:
Phytochemical screening yielded alkaloids, flavonoids, glycosides, saponins, phenols and tannins in the ethanol and aqueous extracts of BC. The 50 % ethanol extract of leaves showed significant antioxidant activity probably from the occurrence of secondary metabolites. (3)
In the ORAC antioxidant assay, a methanolic extract of Barleria cristata, J. procumbens, and S. auriculara exhibited antioxidant activity with ORAC units of 3.1-3.9. (4)
Hepatoprotective / Leaves:
Study evaluated an ethanolic extract of leaves for hepatoprotective activity in a CCl4-induced liver damage model in male Wistar albino rats. Results showed hepatoprotective activity which was attributed to alkaloids and flavonoids. The extract did not show any mortality up to a dose of 2000 mg/kbw. (5)
Anti-Diabetic / Seeds:
Study evaluated alcoholic extracts of dried seeds of Barleria cristata for hypoglycemic activity in alloxan-induced diabetic Wistar rats. Results showed significant blood glucose reduction. (7)
Antibacterial / Flavonoids / Bark:
Study evaluated various extracts for antimicrobial activity against Staphylococcus aureus, Bacillus subtilis, Streptococcus mutans and Escherichia coli. An ethanolic extract exhibited the largest zone of inhibition against the tested bacteria. Study yielded a new flavonoid compound, 6-O-α-L-rhamnopyranoside-3,7,3'-O-trimethylated-8- hydroxyquercetin, together with known flavonoids flavonoids 6- O-α-L-rhamnopyranoside 3-methoxy quercetin, quercetagetin, tamarixetin, gossypetin and quercetin. Gossypetin 8-methyl ether showed the highest antibacterial activity. (8)
Hypoglycemic Effect / Leaves:
Study of ethanolic leaf extract revealed the non-toxic nature of B. cristata. A 400 mg/k dose brought an effective hypoglycemic activity in wistar albino rats. (10)
Anti-Inflammatory / Radical Scavenging Activity:
Study of a methanol extract of Barleria cristata leaves exhibited significant anti-inflammatory against carrageenan induced paw edema in rats and prostaglandins inhibitory activity in mice and radical scavenging activity in in vitro methods by DPPH and NO radicals. (11)
Cytotoxic / Antioxidant / Leaf and Bark:
Study investigated various solvent extracts of B. cristata for cytotoxic and antioxidant activities. Leaf and bark extracts yielded terpenoids, anthraquinones, alkaloids, flavonoids, and saponins. Extracts were tested for cytotoxic activity using Brine shrimp lethality assay. The majority of extracts showed dose dependent activity. Methanol extract of both leaf and bark showed highest activity at 94% and 83%, respectively. The methanol leaf and bark extract showed highest nitric oxide radical scavenging activity, with the bark extract showing more potency (>80%). Methanol and acetone extract of both leaf and bark showed significant cytotoxic and antioxidant activities. (14)
Antihyperglycemic / Leaves:
Study investigated the antihyperglycemic and antioxidant effect of ethanolic leaf extracts of B. cristata in streptozotocin-induced diabetic rats. Results showed significant reduction of blood glucose (P<0.05) in diabetic rats. The antidiabetic effect may be through potentiation of pancreatic secretion of insulin or increase of glucose uptake by muscle cells. (16)
• Silver Nanoparticles / Mosquitocidal Potential: Compared to leaf aqueous extract, biosynthesized AgNP showed higher toxicity against An subpictus, Ae. albopictus, and C. tritaeniorhynchus with LC50 values of 12.46, 13.49, and 15.01 µg/mL, respectively.
Study showed B. cristata-fabricated AgNPs are a promising and eco-friendly tool against young instar populations of mosquito vectors of medical and veterinary importance. (17)
• Iridoid and Phenylethanoid Glucosides / Aerial Parts: Study of aerial parts yielded a new iridoid glycoside, barlupulin C methyl ester (1) together with two known phenylethanoid glycosides (2 and 3) and three known phenolic glycosides (4-6). (see constituents above) (18)

• Toxicity Studies / Leaves and Roots:
Acute toxicity study of leaf extract of B. cristata reported safety up to dose level of 2000 mg/kg p.o. in Wistar albino rats. There was no toxicity or death within 24 hours. A methanolic extract of roots showed no side effects or mortality in mice up to 5 g/kg p.o. during a 24-hr observation period. (19)
• Topical Anti-Inflammatory Activity: Acute evaluated the topical anti-inflammatory activity of various extracts of Barleria cristata and B. prionitis against croton oil-induced edema in female rats. Ibuprofen was used as standard. Maximum effect was noted at dose of 200 mg/ml for all extracts of both species. B. prionitis showed best topical activity with 88.31% inhibition of ear edema. (
• Biological Activities / Leaves: Study evaluated a methanol extract of leaves and various partitionates for antioxidant, cytotoxic, thrombolytic, membrane stabilizing and antimicrobial activities. Extractives exhibited weak free radical scavenging activity. A CCl4-soluble fraction exhibited an IC50 of 300.82 µg/ml with total phenolic content of 89.22 mg of GAE/g of extractives. Brine shrimp lethality bioassay of a hexane soluble fraction yielded an LC50 of1.52 µg/ml. Extractives showed mild thrombolytic activity, with the aqueous soluble fraction exhibiting 45.0 % clot lysis compare to streptokinase and water with 65.66% and 3.79%, respectively. A chloroform solutble fraction showed activity against microbial growth with inhibition range of 7.0 to 26.0 mm. (21)
• Antidiabetic / Antioxidant / Leaves: Study evaluated the in vitro antidiabetic and antioxidant activity of Barleria cristata leaves extracts. An ethanol and petroleum ether leaf extract showed dose-dependent increases in inhibitory activity on α-amylase and α-glucosidase enzymes and antioxidant activity. (22)
• Carcinogenesis Blockers Against Menadione Cytotoxicity: Blocking agents are an important class of chemopreventive compounds that prevent carcinogens from undergoing metabolic activation and suppress interaction with cellular macromolecular targets. Study evaluated phenolic compounds from B. cristata var. alba as chemopreventive agent. An ethyl acetate fraction yielded five known compounds: verbascoside (1), isoverbascoside (2), dimethoxyverbascoside (3), p-hydroxy benzoic acid (4), and apigenin-7-O-glucoside (5). The isolatee compounds were evaluated for potential to induce cancer chemopreventive enzyme marker NAD(P)H quinonereductase 1 (NQO1) in murine Hepa-1c1c7 cell model. Compound 2, isoverbascoside, potently induced activity of the enzyme in a dose-dependent manner. The compound was the strongest to protect Hepa-1c1c7 against the toxicity of menadione, a quinone substrate for NQO1. Results suggest the compound has potential to induce both catalytic activity and protein expression of NQO1 as revealed by enzyme assay and Western blotting, respectively. (see constituents above) (23)
• Antimicrobial / Saponins / Leaves: A simple HPTLC method evaluated the saponin profile of B. cristata crude leaf extract. The saponin fraction was evaluated for in vivo activity against four bacterial and four fungal species by agar disc diffusion method. The most inhibited organisms were K.lebsiella pneumonia, Staphylococcus aureus, Escherichia coli, and Aspergillus parasites. (24)
• Gold Nanoparticles / Antimicrobial / Anticancer / Leaves: Study reported on the eco-friendly synthesis of gold nanoparticles using B. cristata leaves. Disc diffusion method confirmed the extracts antibacterial properties in vitro. MTT assay confirmed the extract's anticancer properties on HeLa carcinoma cell lines, with IC50s of 50 µg/mL. (27)
• Antidiabetic / Hypolipidemic / Leaves: Study evaluated the antidiabetic and hypolipidemic action of leaf extract of B. cristata in diabetic rats induced by alloxan. Animals were treated with 250 and 500 mg/kg doses of ethyl acetate leaf extract (EALE) and hydro-alcoholic extract (HALE) for 21 days. Daily administration of HALE and EALE significantly (p<0.05) reduced elevated BGL, regained body weight, and improved hepatic and renal functioning evidenced by restoration of biochemical profile. Results suggest antidiabetic and hypolipidemic activity. (28)
• Antimicrobial Against Endodontic Pathogens: Study evaluated the antimicrobial potential of methanolic leaf extracts of B. cristata against common endodontic pathogens i.e., E. faecalis and P. endodontalis. Results showed the percentage of zone inhibition increased with increasing concentrations, greater for E. faecalis compared to P. endodontalis. Results suggest basis for use of the leaf extract of Barleria cristata in the disinfection of the root canal system. (30)
• Cardioprotective / Leaves: Study evaluated the in vivo cardio-protective activity of ethanolic extract of leaves of B. cristata using Daphnia magna as model. Acute toxicity study per OECD guidelines 202 revealed no significant mortality up to 6 µg/ml of ethanolic extract of leaves.  Ethanol extract doses of 20, 40, 60, 80, and 100 µg/ml were tested on lactose induced arrthythmia of Daphnia magna and compared with standard metoprolol. Results showed dose dependent cardio-protective activity. (31)
• Zinc Nanoparticles / Antibacterial / Antifungal / Leaves: Study reports on the green synthesis of biologically active zinc oxide (ZnO) nanoparticles using biocomponents of leaves extract of B. cristata. The ZnONPs showed strong antibacterial and good antifungal activity against selected strains of bacterial and fungus (Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Aspergillus niger). (32)


Updated July 2024 / July 2020 / January 2017

                                                   PHOTOS / ILLUSTRATIONS
Photos © Godofredo Stuart / StuartXchange
IMAGE SOURCE: Barleria spp Blanco / Francisco Manuel Blanco (OSA), 1880-1883 / Flora de Filipinas/ Wikimedia Commons
IMAGE SOURCE: Barleria cristata / J M Garg / CC BY 3.0 / Click on image or link to go to source page / Wikipedia

Additional Sources and Suggested Readings
Evaluation of anti-inflammatory activity of methanol extract of Barleria Cristata leaves by in vivo and in vitro methods / Manoh Gambhire M et al / The Internet Journal of Pharmacology, 2009; Volume 7 No 1

Antiinflammatory activity of aqueous extract of Barleria cristata leaves / M N Gambhire, SS Wankhede, AR Juvekar / J Young Pharm, 2009; 1(3): pp 220-224 / DOI: 10.4103/0975-1483.57068
In Vitro Antioxidant Activity of Ethanolic Extract of Barleria cristata L. Leaves / K Amutha and Victor Arokia Doss / Research Journal of Pharmacognosy and Phytochemistry, 2009; 1(3) / DOI: 10.5958/0975-4385 
Part 1: Antiplasmodial, cytotoxic, radical scavenging and antioxidant activities of Thai plants in the family Acanthaceae.
/ Panarat Charoenchai, Srunya Vajrodaya, Winai Somprasong, Chulabhorn Mahidol, Somsak Ruchirawat, Prasat Kittakoop, Chulabhorn Research Institute, Bangkok, Thailand. / Planta Medica, 11/2010; 76(16):1940-3. / DOI:10.1055/s-0030-1250045
IN-VIVO HEPATOPROTECTIVE ACTIVITY OF Barleria cristata L. ETHANOLIC LEAF EXTRACTS AGAINST CCl4 INDUCED HEPATIC INJURY IN WISTAR RATS / P Balaji, G Kishore, Yogendra Verma / Pharmacie Globale (IJCP) 2013, 4(4): pp 1-6
PHENYLETHANOID GLYCOSIDES FROM BARLERIA CRISTATA L. CALLUS CULTURES / A. M. A. Abd El-Mawl1, A. S. Ahmed, Z. Z. Ibraheim1 and L. Ernst / Bull. Pharm. Sci., Assiut University, Vol. 28, Part 2, December 2005, pp. 199-204.
Screening for anti-diabetic activity of the ethanolic extract of Barleria cristata seeds / Ranjit Singh, P. H. Rajasree and C. Sankar / INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES, 2012; 3(10): pp 2044-2047 / ISSN: 0976-7126
Antibacterial activity of Barleria cristata bark extracts / Josline Y. Salib, Nabila H. Shafik, Helana N. Michael, Emad F. Eskander / Journal of Applied Sciences Research, 9(3): 2156-2159, 2013
Barleria cristata Linn.: Phytochemical Screening and HPTLC Analysis / Rajasekaran Narmadha and Kanakasabapathi Devaki / International Research Journal of Pharmacy, 2012, 3(7).
Toxicological evaluation and oral glucose tolerance test of ethanolic leaf extract of Barleria cristata L. in wistar albino rats / R. Narmadha, K. Devaki / Int J Basic Clin Pharmacol. 2013; 2(6): 742-746doi: 10.5455/2319-2003.ijbcp20131213
Evaluation of anti-inflammatory and radical scavenging activity of an aqueous extract of Barleria cristata leaves / M Gambhire, M Juvekar, A Juvekar, S Wankhede, S Sakat / Planta Med 2009; 75 - PJ166
DOI: 10.1055/s-0029-1234971
Barleria cristata L. / Synonyms / KEW: Plants of the World Online
Barleria cristata / Vernacular names / EOL
4-Hydroxy-trans-cinnamate Derivatives and Triterpene from Barleria cristata / Nipa Chowdhury, Abdullah Al Hasan, Fakir Shahidullah Tareq, Monira Ahsan and A.T.M. Zafrul Azam / Dhaka Univ. J. Pharm. Sci. 12(2): 143-145, 2013 (December)
In Vivo Assessment of Antioxidants and Antihyperglycemic Effect of Barleria cristata leaves in Streptozotocin- Induced Diabetic Rats / Narmadha Rajasekaran, Gomathi Duraisamy, Kalaiselvi Manokaran, Devaki Kanakasapathi / International Journal of Applied Sciences and Biotechnology, 2014; Vol 2, No 4
Facile biosynthesis of silver nanoparticles using Barleria cristata: mosquitocidal potential and biotoxicity on three non-target aquatic organisms / Marimuthu Govindarajan / Parasitology Research, March 2016, Volume 115, Issue 3, pp 925–935
Iridoid and phenylethanoid glycosides from the aerial part of Barleria lupulina / Seoung Rak Lee, Jon Clardy, Donald Robert Senger, Shugeng Cao * / Ki Hyun Kim * / Rev. bras. farmacogn. vol.26 no.3 Curitiba May/June 2016 / http://dx.doi.org/10.1016/j.bjp.2016.01.002
Barleria cristata : perspective towards phytopharmacological aspects  / Harish Kumar, Rohini Agrawal, Vipin Kumar / Journal of Pharmacy and Pharmacology, 70(4) / https://doi.org/10.1111/jphp.12881
Topical anti-inflammatory studies on Barleria prionitis and B. cristata. / Maninder Karan, Kawl Preet, Karan Vasisht / Journal of Pharmaceutical and Biomedical Sciences, 2013
Biological activities of Barleria cristata / Tasnuva Sharmin, Shahanaz Ahmed, and Farhana Islam / IJRPP, 2013; 2(2): pp 367-371
EVALUATION OF IN VITRO ANTIDIABETIC AND ANTIOXIDANT POTENTIAL OF BARLERIA CRISTATA LEAVES EXTRACTS / Sakthivel Vasanth, Giridharan Bupesh, Tharumasivam Siva Vijayakumar, Vellingiri Balachandar, Durai Rajan Gunasekaran / Asian Journal of Pharmaceutical and Clinical Research, 2018; 11(4) / / DOI https://doi.org/10.22159/ajpcr.2018.v11i4.24069
Phenolics from Barleria cristata var. Alba as carcinogenesis blockers against menadione cytotoxicity through induction and protection of quinone reductase / Ali M. El-HalawanyHossam M. AbdallahAhmed R. HamedHany Ezzat Khalil & Ameen M. Almohammadi  / BMC Complementary Medicine and Therapies, 2018; 18: Article No 163 / https://doi.org/10.1186/s12906-018-2214-9
IDENTIFICATION AND ANTIMICROBIAL ACTIVITY OF SAPONIN FRACTION FROM THE LEAVES OF BARLERIA CRISTATA L. / K. Amutha and D. Victor Arokia Doss / International Journal of Pharmaceutical Sciences and Research, 2012; 3(10):pp 4040-4044
Chemical Constituents Isolated From Leaves Of Barleria Cristata Linn. / K. Hemalatha, N. Hareeka And D. Sunitha / Int J Pharm Bio Sci., Jan-Mar 2012; 3(1): pp 609-615
Barleria cristata Medicinal Uses | Philippine Violet Medicinal Uses / Rajkumar / Malars of India
Synthesis and characterization of gold nano particles using barleria cristata for antimicrobial and anticancer applications / Sivaraman Baskar, Sivaraman Kanithan, Namani Srinivas, S Govinda Rao, Tara Singla / MATEC Web of Conferences, 2024; Vol 392: Art No 01036 /
DOI: 10.1051/matecconf/202439201036
Evaluation of antidiabetic and hypolipidemic activity of Barleria cristata Linn. leaves in alloxan-induced diabetic rats / Mohd Nazam Ansari, Abdulaziz S Saeedan, Sakshi Bajaj, Lakhveer Singh / 3Biotech, 2021; Volume 11, Article No 170 / DOI: 10.1007/s13205-021-02728-5
Antimicrobial Efficacy of Barleria Cristata Leaves against Persistent Endodontic Pathogens - An In Vitro Analysis. / S K Swarna, M S Nivedhitha / International Journal of Pharmaceutical Research, 2020 /
ISSN: 0975-2366 / DOI: 10.31838/ijpr/2020.SP1.410
Assessment of cardio-protective activity of Barleria cristata Linn. using Daphnia magna as model
/ Kowsalya J, B Kumudhaveni, M Jiyavutheen, M Kavithasai, R Radha / Research Journal of Pharmacy and Technology, 2023; 16(4): pp 1587-1592 / DOI: 10.52711/0974-360X.2023.00259 / pISSN: 0974-3618 / eISSN: 0974-360X
SYNTHESIS OF ZINC OXIDE NANOPARTICLES USING LEAF EXTRACT OF BARLERIA CRISTATA AND MICROBIAL ACTIVITY / G Madan Kumar, G Kalpana / World Journal of Pharmaceutical Research, 6(2): pp 544-552 / ISSN: 2277-7105 / DOI: 10.20959/wjpr20172-7166




DOI: It is not uncommon for links on studies/sources to change. Copying and pasting the information on the search window or using the DOI (if available) will often redirect to the new link page. (Citing and Using a (DOI) Digital Object Identifier)

                                                            List of Understudied Philippine Medicinal Plants
                                          New plant names needed
The compilation now numbers over 1,500 medicinal plants. While I believe there are hundreds more that can be added to the collection, they are becoming more difficult to find. If you have a plant to suggest for inclusion, native or introduced, please email the info: scientific name (most helpful), local plant name (if known), any known folkloric medicinal use, and, if possible, a photo. Your help will be greatly appreciated.

HOME      •      SEARCH      •      EMAIL    •     ABOUT